OrbiMed Advisors

Overview

Overall Ranking (77%)

The Overall Ranking is a score from 1 star (very bad) to 5 stars (excellent) generated based on the Company Reviews of current and former employees at this company, taking everything into account.

The number you see in the middle of the donut pie chart is the simple average of these scores. If you hover over the various sections of the donut, you will see the % breakdown of each score given.

The percentile score in the title is calculated across the entire Company Database and uses an adjusted score based on Bayesian Estimates (to account for companies that have few reviews). Simply put, as a company gets more reviews, the confidence of a "true score" increases so it is pulled closer to its simple average and away from the average of the entire dataset.

The Overall Ranking is generated based on the Company Reviews.

3.7
  • 5 Stars
  • 4 Stars
  • 3 Stars
  • 2 Stars
  • 1 Star

Company Details

Healthcare-focused investment management firm with over $7bn in capital managed across public and private investments

From biopharmaceuticals to medical devices, diagnostics, and healthcare services, OrbiMed is scouting the globe for innovations that will help ensure humanity lives healthier, longer and more productive lives. We have been investing globally for over 20 years across the healthcare industry: from early-stage private companies to large multinational corporations. Our team of over 80 distinguished scientific, medical, investment and other professionals manages over $13 billion across public and private company investments worldwide.

Locations

Location

601 Lexington Avenue (at 53rd Street)
54th Floor
New York, NY 10022
United States

Get Full Access

 or Register to Contribute

OrbiMed Advisors Interview Questions

Recent interviews

View all
YearPositionLocationGroup/DivisionExperienceDifficulty
2016Student / Prospective MonkeyNew YorkHedge FundPositiveAverage
2017InternNew YorkInvestment BankingPositiveAverage
2014Investment AnalystNew YorkPharmaceuticalsPositiveAverage
20141st Year AnalystNew YorkHealthcarePositiveAverage

OrbiMed Advisors

Hedge Funds

Est Annual Revenue:
$10m+
AUM:
$5bn-$8bn

Industry: Asset Management